123 related articles for article (PubMed ID: 32242855)
1. ELEVATED LEVELS OF NATURALLY OCCURRING AUTOANTIBODIES TO HUMAN CHORIONIC GONADOTROPIN Β CORE FRAGMENT IN A FEMALE PATIENT WITH THYROID FOLLICULAR ADENOMA: CASE REPORT.
Chikadze N; Tevzadze M; Gachechiladze N; Porakishvili N
Georgian Med News; 2020 Feb; (299):106-110. PubMed ID: 32242855
[TBL] [Abstract][Full Text] [Related]
2. NATURALLY-OCCURRING AUTOANTIBODIES TO HUMAN CHORIONIC GONADOTROPIN AND ITS SUBUNITS IN OVARIAN CYST PATIENTS.
Chikadze N; Tevzadze M; Janelidze M; Porakishvili N
Georgian Med News; 2020 Jan; (298):100-105. PubMed ID: 32141859
[TBL] [Abstract][Full Text] [Related]
3. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
4. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
5. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
6. The origin of a human chorionic gonadotropin beta-subunit-core fragment excreted in the urine of patients with cancer.
Papapetrou PD; Nicopoulou SC
Acta Endocrinol (Copenh); 1986 Jul; 112(3):415-22. PubMed ID: 2428192
[TBL] [Abstract][Full Text] [Related]
7. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
8. hCGbeta core fragment is a metabolite of hCG: evidence from infusion of recombinant hCG.
Norman RJ; Buchholz MM; Somogyi AA; Amato F
J Endocrinol; 2000 Mar; 164(3):299-305. PubMed ID: 10694369
[TBL] [Abstract][Full Text] [Related]
9. Determination of the glycoforms of human chorionic gonadotropin beta-core fragment by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jacoby ES; Kicman AT; Laidler P; Iles RK
Clin Chem; 2000 Nov; 46(11):1796-803. PubMed ID: 11067815
[TBL] [Abstract][Full Text] [Related]
10. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
Nerenz RD; Song H; Gronowski AM
Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
[TBL] [Abstract][Full Text] [Related]
11. Characterizing urinary hCGβcf patterns during pregnancy.
Nerenz RD; Yarbrough ML; Stenman UH; Gronowski AM
Clin Biochem; 2016 Jul; 49(10-11):777-81. PubMed ID: 27087510
[TBL] [Abstract][Full Text] [Related]
12. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
13. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
Okamoto T
Nihon Rinsho; 2010 Jul; 68 Suppl 7():803-6. PubMed ID: 20963909
[No Abstract] [Full Text] [Related]
14. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
15. Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
Ordóñez NG; Ayala AG; Raymond AK; Plager C; Benjamin RS; Samaan NA
Arch Pathol Lab Med; 1989 Apr; 113(4):416-9. PubMed ID: 2468324
[TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high affinity naturally occurring IgG2 antibodies against human chorionic gonadotropin and its subunits in patients with ovarian cyst.
Chikadze N; Tevzadze M; Janelidze M; Lydyard P; Porakishvili N
Immunobiology; 2022 Nov; 227(6):152273. PubMed ID: 36088866
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotrophin immunoactivity in cystic intracranial tumours.
Honegger J; Mann K; Thierauf P; Zrinzo A; Fahlbusch R
Clin Endocrinol (Oxf); 1995 Mar; 42(3):235-41. PubMed ID: 7538923
[TBL] [Abstract][Full Text] [Related]
19. Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia.
Bahado-Singh RO; Oz U; Isozaki T; Seli E; Kovanci E; Hsu CD; Cole L
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):738-41. PubMed ID: 9757981
[TBL] [Abstract][Full Text] [Related]
20. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
